Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
:BPTH
Bp1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide, Decitabine (In Combination With Bp1002)
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, In Relapse
Phase I
Recruiting
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
Dec 08, 2021
―
Bp1001-A (Liposomal Grb2 Antisense Oligonucleotide), Bp1001-A (Liposomal Grb2 Antisense Oligonucleotide) With Paclitaxel
Solid Tumor, Solid Tumor, Adult, Endometrial Cancer, Peritoneal Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms
Phase I
Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Dec 10, 2019
―
L-Bcl-2 Antisense Oligonucleotide
Follicular Lymphoma, Marginal Zone Lymphoma, Dlbcl, Mantle Cell Lymphoma, Waldenstrom Macroglobulinemia, Hodgkin Lymphoma, Small Lymphocytic Lymphoma (Sll), Chronic Lymphocytic Leukemia (Cll), Peripheral T-Cell Lymphoma (Ptcl), Cutaneous T-Cell Lymphoma (Ctcl)
Phase I
Active Not Recruiting
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
Aug 23, 2019
―
Bp1001 In Combination With Ventoclax Plus Decitabine, Bp1001 Plus Decitabine
Acute Myeloid Leukemia (Aml)
Phase II
Recruiting
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
May 18, 2016
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bio-Path Holdings (BPTH) have in its pipeline
BPTH is currently developing the following drugs: Bp1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide, Decitabine (In Combination With Bp1002), Bp1001-A (Liposomal Grb2 Antisense Oligonucleotide), Bp1001-A (Liposomal Grb2 Antisense Oligonucleotide) With Paclitaxel, L-Bcl-2 Antisense Oligonucleotide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.